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In endothelial cells nitric oxide (NO) is synthesized by endothelial-nitric oxide
synthase (e-NOS), constitutively expressed and encoded by a 26-exon gene, lo-
cated on chromosome 7q35-36. The prevalence of the T rare variant of the G894T
polymorphism in exon 7 of the e-NOS gene (Glu!Asp amino acid substitution)
has been reported to be significantly higher in patients with coronary spasm and
coronary artery disease. To date G894T polymorphism detection is performed
by PCR-RFLP assay. In order to establish a high-speed genotyping method, we
have taken advantage of the Light Cycler instrument, a thermal cycler that com-
bines rapid-cycle DNA amplification with a real-time fluorescence monitoring.
This technology is based on hybridization of the adjacent fluorescently labeled
probes with PCR products. This methodology is considered more accurate and
less time-consuming than conventional PCR-RFLP assay. To validate this tech-
nique we genotyped 270 healthy subjects. The results were consistent with those
obtained from PCR-RFLP assay.
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INTRODUCTION
Nitric oxide (NO), a potent regulator of the cardiovascular system, is synthesized
from L-arginine by a family of three NO synthases (NOS): neuronal (n-NOS,
type I), inducible (i-NOS, type II), and endothelial (e-NOS, type III) (Wang and
Marsden, 1995). In endothelial cells, NO is synthesized by the e-NOS, consti-
tutively expressed, encoded by a 26-exon gene located on chromosome 7q35-
36 (Marsden et al., 1993). Endothelium-derived NO controls the vascular tone,
inhibits platelet (Radomski et al., 1987) and leucocyte adhesion to vascular en-
dothelium (Kubes et al., 1991), inhibits smooth muscle cell migration (Sarkar et al.,
1996) and growth (Garg and Hassid, 1989), and limits the oxidation of atherogenic
low-density lipoproteins (Hogg et al., 1993). These mechanisms suggest an impor-
tant atheroprotective role, beyond its effect on vessel tone and blood pressure, and
that an alteration in the vascular NO system activity could contribute to the patho-
genesis of atherosclerosis. The e-NOS human gene exhibits many polymorphisms,
some of which seem related to a significant proportion of the variance of NO plas-
matic levels. A point mutation of guanine to thymine at nucleotide 894 in exon 7 of
the eNOS gene, which results in the replacement of glutamic acid by aspartic acid
at codon 298 (Glu298Asp) has been described (Hingorani et al., 1995). It has been
demonstrated that this polymorphism is not silent and may possibly be perceived
as a target for cleavage (Tesauro et al., 2000). Evidence has been presented that
this polymorphism is associated with coronary spasm (Yoshimura et al., 1998),
acute myocardial infarction, and coronary artery disease in Caucasians (Hingorani
et al., 1999).
EXPERIMENTAL PROCEDURE
To date, G894T polymorphism detection for e-NOS is performed by polymerase
chain reaction (PCR), followed by restriction fragment length polymorphism
(RFLP) analysis through digestion with the MboI restriction enzyme and resolu-
tion by electrophoresis on agarose gel (Hingorani et al., 1999). In order to establish
a high-speed and facile genotyping method, we have taken advantage of the Light
Cycler (Roche Diagnostics), a microvolume fluorometer integrated with a thermal
cycler that combines rapid-cycle DNA amplification with real-time fluorescence
monitoring (Wittwer et al., 1997). This technology is based on hybridization of
amplicon-specific oligonucleotide probes, labeled with adjacent fluorophores ca-
pable of fluorescence resonance energy transfer (FRET) introduced in a thermal
cycler (Light Cycler) that uses glass capillaries and hot air for heating. The probes
are designed to hybridize to the same strand between the two unlabeled primers.
A detection probe (Sensor probe), which matches the rare allele sequence, is la-
beled at its 30-end with fluorescein (FLU). Moreover, a second hybridization probe
(Anchor probe) is labeled at the 50-end with a Light Cycler red fluorophore (LC
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     GCCCCAGATGATCCCCCAGAACTC        CCTTC T GCCCCCCGAGCTGGTCC 




                                                                ACGTGAGCACCAAAGGGATTG -3’ 
                                                                TGCACTCGTGG TTTC CCTAAC-5’ 
NOS F (forward primer) 
NOS R (reverse primer) 
SENSOR PROBE (3’-FLU) ANCHOR PROBE (5’-LC Red640) 
Fig. 1. Schematic showing positions of primers and hybridization probes for amplification and geno-
typing of eNOS G894T polymorphism site. An amplicon that spans the area of the polymorphism site
is created with the unlabeled primers. Two hybridization probes anneal to the same strand internal
to the unlabeled primers. The Sensor probe is labeled at its 30-end with fluorescein (FLU), and the
Anchor probe is labeled at its 50-end with a Light Cycler red fluorophore (LC Red 640).
Red 640) (Fig. 1). When both probes hybridize in close proximity (in a head-to-
tail manner), fluorescence energy transfer between the donor fluorophore (FLU),
which is excited by a LED (light emitting dye) light source of the instrument
(‚ D 530 nm), and the acceptor fluorophore (LC Red 640) occurs. The acceptor
fluorophore emits light of a longer wavelength (‚ D 640 gm), which is detected
in specific channels of the instrument.
For e-NOS G894T polymorphism genotyping, genomic DNA was isolated
and purified from EDTA blood using QIAamp spin columns according to the man-
ufacturer’s instructions (QIAamp Blood Kit, Qiagen, GmbH, Hilden, Germany).
Light Cycler (LC) amplification is performed in a final volume of 20 „L in the
LC-glass capillaries. The reaction mixture consisted of 12.4 „L of H2O, 0.8 „L
of MgCl2 (25 mM), 10 pmol of each primer, NOSF (50-CACTCCCCACAGCTCT
GCAT-30) and NOSR (50-CAATCCCTTTGGTGCTCACG-30), 4 pmol of An-
chor probe, 4 pmol of Sensor probe, and 2 „L of DNA-Master hybridization
probes (Reaction Buffer). Two microliters of genomic DNA (50–200 ng/„L) were
used for amplification. Fluorescently labeled hybridization probes were synthe-
sized by TIB Molbiol (Berlin, Germany). The Anchor probe, 50-LC Red 640-
CCTTCTGCCCCCCGAGCTGGTCC-30-P, was 50 labeled with the LC-Red 640
fluorophore and phosphorylated (P) at its 30-end to prevent probe elongation by the
Taq polymerase. The detection probe, 50-CCCCAGATGATCCCCCAGAACTC-
30, was labeled with fluorescein (FLU) at its 30-end.
Cycling conditions for e-NOS G894T polymorphism detection include an
initial denaturation at 95–C for 30 s, followed by 45 cycles with a fast denaturation
at 95–C with an incubation time of 0 s, annealing at 62–C for 10 s and extension
at 72–C for 12 s with a ramping time of 20–C/s. After amplification, melting
curves were generated following a fast denaturation of the reaction at 95–C with an
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Fig. 2. Melting curves (fi) are converted to melting peaks (fl) by plotting the negative derivative of
fluorescence with respect to temperature (¡dF/dT). (A) The typical melting curve pattern, obtained
when the Sensor probe hybridizes with the specific DNA sequence (894T rare allele), is a single melting
peak at a temperature of 65.5–C. The picture shows a homozygous genotype for T rare allele (TT). (B)
For the common allele (894G) there is a mismatch between the PCR product and the Sensor probe,
which leads to strand instability and consequent earlier melting. The result is a single melting peak at
a temperature of 60.5–C. The picture shows a homozygous genotype for the common G allele (GG).
(C) Heterozygous patients show two melting peaks, one at 60.5–C and one at 65.5–C. The picture
shows a heterozygous genotype (GT).
incubation time of 0 s, holding the sample at 52–C for 30 s and then slowly heating
the sample to 75–C with a ramp rate of 0.1–C/s. Melting curves were converted
to melting peaks by calculating the negative derivative of the fluorescence with
respect to temperature (–dF/dT) against temperature. This plot allows distinction
of the common allele from the rare one.
The typical melting curve pattern, obtained when the Sensor probe hybridizes
with the specific DNA sequence (894T rare allele), is a single melting peak at
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Fig. 2. (Continued).
a temperature of 65.5–C (Fig. 2(A)). For the common allele (894G) there is a
mismatch between the PCR product and the Sensor probe, which leads to strand
instability and consequent earlier melting. The result is a single melting peak at a
temperature of 60.5–C (Fig. 2(B)). Heterozygous patients show two melting peaks
(60.5 and 65.5–C) (Fig. 2(C)).
To validate this technique, we genotyped 270 healthy subjects recruited from
blood donors: 61 subjects were homozygous for the mutant 894T allele (TT,
22%), 172 were heterozygous (GT, 64%), and 145 were homozygous for the
G allele (GG, 54%). The 894T allele frequency was 0.33 (Table I). The geno-
types were easily and clearly identified by generation of characteristic fluores-
cence melting peaks. We have compared this technique with the results obtained
with a conventional method (PCR-RFLP): in each case, identical genotypes were
obtained.
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Fig. 2. (Continued).
This methodology gives more accurate results than conventional PCR-RFLP-
based assay because it minimizes PCR contamination concerns related to sample
handling and does not require digestion of PCR products with restriction enzymes
and/or fragment separation on gels; it also does not require the use of hazardous
reagents such as ethidium bromide and permits high-speed genotyping (i.e., 30
Table I. Distribution of Genetic Polymorphisms of the eNOS G894T Polymorphism
eNOS 894 TT GT GG T G
Genotype 61 (22%) 172 (64%) 145 (54%)
Allele frequency 0.33 0.67
(Healthy Subjects n D 270).
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samples can be analyzed in less than 2 h, instead of 8 h needed for PCR-RFLP
assay).
In conclusion, this assay has shown its reliability and rapid practicability. It
is especially suitable for molecular diagnostic routine laboratories, where a large
number of samples must be processed.
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